J-Pharma

520A.TTSE GROWTHPharmaceutical
Major holders (5%+) · 3
HolderStakeChangeFiled
JIC Venture Growth Investments Co., Ltd.11.34%—2026-04-01
Eight Roads Ventures Japan II LP10.88%—2026-03-31
Newton Biocapital I, pricaf privee de droit belge6.87%—2026-03-26

Each holder's own ratio from its most recent large-shareholding report.

Ownership history · 3
FiledHolderRatioChangePurpose
2026-04-01JIC Venture Growth Investments Co., Ltd.2026-04-0111.34%newPure investment
2026-03-31Eight Roads Ventures Japan II LP2026-03-3110.88%newPure investment
2026-03-26Newton Biocapital I, pricaf privee de droit belge2026-03-266.87%newPure investment

Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.